Viewing Study NCT03711058

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:08 AM
Ignite Modification Date: 2026-03-04 @ 8:46 PM
Study NCT ID: NCT03711058
Status: COMPLETED
Last Update Posted: 2025-09-16
First Post: 2018-10-15
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Study of PI3Kinase Inhibition (Copanlisib) and Anti-PD-1 Antibody Nivolumab in Relapsed/Refractory Solid Tumors With Expansions in Mismatch-repair Proficient (MSS) Colorectal Cancer
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Unresectable or Metastatic Microsatellite Stable (MSS) Solid Tumor View
None Microsatellite Stable (MSS) Colon Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Immunotherapy View
None Nivolumab View
None Copanlisib View
None Unresectable View
None Metastatic View
None PD-1 View
None P13K View
None Antibody View
None Solid Tumors View
None Colon Cancer View
None MSS View
None Mismatch-repair proficient View
None Microsatellite stable View